Gw. Buchko et al., STRUCTURAL STUDIES OF A PEPTIDE ACTIVATOR OF HUMAN LECITHIN-CHOLESTEROL ACYLTRANSFERASE, The Journal of biological chemistry, 271(6), 1996, pp. 3039-3045
The synthetic lipid-associating peptide, LAP-20 (VSSLLSSLKEYWSSLKESFS)
, activates lecithin-cholesterol acyltransferase (LCAT) despite its la
ck of sequence homology to apolipoprotein A-I, the primary in vivo act
ivator of LCAT. Using SDS and dodecylphosphocholine (DPC) to model the
lipoprotein environment, the structural features responsible for LAP-
20's ability to activate LCAT were studied by optical and two-dimensio
nal H-1 NMR spectroscopy. A large blue shift in the intrinsic fluoresc
ence of LAP-20 with the addition of detergent suggested that the pepti
de formed a complex with the micelles, Analysis of the CD data shows t
hat LAP-20 lacks well defined structure in aqueous solution but adopts
helical, ordered conformations upon the addition of SDS or DPC. The h
elical nature of the peptides in the presence of both lipids was confi
rmed by upfield H-alpha NMR secondary shifts relative to random coil v
alues. Average structures for both peptides in aqueous solutions conta
ining SDS and DPC were generated using distance geometry methods from
329 (SDS) and 309 (DPC) nuclear Overhauser effect-based distance restr
aints. The backbone (N, C-alpha, C=O) RMSD from the average structure
of an ensemble of 17 out of 20 calculated structures was 0.41 +/- 0.15
Angstrom for LAP-20 in SDS and 0.41 +/- 0.12 Angstrom for an ensemble
of 20 out of 20 calculated structures for LAP-20 in DPC. In the prese
nce of SDS, the distance geometry and simulated annealing calculations
show that LAP-20 adopts a well defined class A amphipathic helix with
distinct hydrophobic and hydrophilic faces. A similar structure was o
btained for LAP-20 in the presence of DPC, suggesting that both deterg
ents may be used interchangeably to model the lipoprotein environment.
Conformational features of the calculated structures for LAP-20 are d
iscussed relative to models for apolipoprotein A-I activation of LCAT.